Personalized medicine for brain health:
From treating the illness to treating the individual
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing. Genomind’s expert staff is comprised of pioneering researchers and thought leaders in psychiatry and neurology who specialize in pharmacogenetic laboratory testing for psychiatry. Genomind is committed to partnering with clinicians to improve their patients’ lives.
Awards and Recognition
Genomind is proud to have been honored for our success in the field. Here are just a few of our accomplishments.
Fastest-growing U.S. private firms
Philadelphia Business Journal
2017 Health Care Innovator Awards
Best Places to Work in Healthcare
Life Sciences Pennsylvania
Emerging Company of the Year
The Genecept Assay® is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions.
Genecept is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, attention deficit hyperactivity disorder (ADHD) and more.
Genecept has been shown in peer reviewed published studies to improve patient outcomes and reduce overall medical costs. Each test provides clinicians with an easy to read patient report and a complimentary psychopharmacogenomic consultation.